Xilio Therapeutics

About:

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Website: https://www.xiliotx.com

Twitter/X: xiliotx

Top Investors: RA Capital Management, MRL Ventures Fund, F-Prime Capital, Deerfield, Ipsen

Description:

Xilio Therapeutics is a biotechnology company. They offer cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. Their tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects.